Bulletin
Investor Alert

London Markets Close in:

SPDR S&P Biotech ETF

NAR: XBI

GO
/marketstate/country/us

Market open

XBI
/quotes/zigman/477927/composite

$

62.22

Change

+1.08 +1.77%

Volume

Volume 2.63m

Dec 2, 2016, 11:06 a.m.

Real time quotes

/quotes/zigman/477927/composite

Previous close

$ 61.14

$ 62.22

Change

+1.08 +1.77%

Day low

Day high

$60.60

$62.67

Open
Open: 61.11

52 week low

52 week high

$44.16

$71.87

Open

Market cap

N/A

Average volume

7.05M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

N/A

Dividend

0.03

Div yield

0.20%

Ex dividend date

9/16/16

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/xbi

MarketWatch News on XBI

  1. Gundlach warns Trump trade is ‘losing steam’ and stocks have peaked

    8:44 a.m. Today

    - Victor Reklaitis

  2. Five ways to evaluate an Obamacare replacement plan

    8:51 a.m. Dec. 1, 2016

    - Emma Court

  3. SPDR S&P Biotech ETF drops 3.3% in premarket trade

    9:24 a.m. Nov. 23, 2016

    - Tomi Kilgore

  4. Stock market fear factor rises as Clinton-Trump race tightens

    8:15 a.m. Nov. 2, 2016

    - Wallace Witkowski

/news/nonmarketwatch/company/us/xbi

Other News on XBI

  1. Investing In A Six-Sigma Market

    9:59 a.m. Dec. 1, 2016

    - Seeking Alpha

  2. 3 Biotech Stocks to Buy in December

    9:08 a.m. Dec. 1, 2016

    - Motley Fool

  3. Why AbbVie Wants to Develop Anti-Tau Therapies

    6:48 p.m. Nov. 30, 2016

    - MarketRealist.com

  4. AbbVie’s Financial Guidance for 2017

    2:00 p.m. Nov. 29, 2016

    - MarketRealist.com

  5. Label Expansion May Boost Venclexta’s Growth Prospects

    2:00 p.m. Nov. 29, 2016

    - MarketRealist.com

  6. What Do Analysts Recommend for Gilead Sciences Stock?

    12:44 a.m. Nov. 26, 2016

    - MarketRealist.com

  7. Will Market 'Trump-Phoria' Last?

    11:01 p.m. Nov. 24, 2016

    - Seeking Alpha

/news/pressrelease/company/us/xbi

Press Releases on XBI

  1. Biotech Industry on the Upswing after Rocky Start to 2016

    8:19 a.m. Aug. 17, 2016

    - ACCESSWIRE

Rates »

5 yr CD
1.2%
2 yr CD
0.8%
1 yr CD
0.6%
MMA $10K+
0.3%
MMA $50K+
0.4%

National averages from Bankrate.com

You Don’t Need Another Credit Card, You Need A Better One.
Avg. APR Last Week 6 Months
Low Interest 12.00% 12.00% 11.96%
Business 13.12% 13.12% 13.12%
Student 13.42% 13.42% 13.42%
Balance Transfer 14.41% 14.41% 14.39%
Airline 15.13% 15.13% 15.17%
Reward 15.24% 15.24% 15.30%
Cash Back 15.33% 15.33% 15.30%
Instant Approval 17.86% 17.86% 18.04%
Bad Credit 22.86% 22.86% 22.56%
Source:CreditCards.com
Trending Tickers
  • /quotes/zigman/107036/composite ULTA+0.13%
  • /quotes/zigman/5419837/composite P+10.02%
  • /quotes/zigman/388552/composite UA-1.55%
  • /quotes/zigman/12221594/composite AMBA-7.69%
  • /quotes/zigman/3144611/composite AG+8.55%
X
Powered by StockTwits
Link to MarketWatch's Slice.